Smoking cigarettes can lead to illness and death. Cigarette smoking is the leading preventable cause of death in the U.S., according to the Centers for Disease Control and Prevention. Understanding why is a challenge, given that cigarette smoke is a complex mixture of more than 7,000 compounds. Much of the blame has been placed on the 93 cigarette-related carcinogens and toxins on the U.S. Food and Drug Administration's list of hazardous and potentially hazardous chemicals. But previous studies have reported that risk assessments based on these compounds underestimate the actual number of illnesses caused by smoking.
Accounting for free radicals, which are known to cause oxidative damage in the body, could help fill that gap. But they are not listed on the FDA's list and are difficult to study because they don't stick around for long. Researchers wanted to find a reliable way to measure free radicals in cigarette smoke.
Now researchers report in ACS' journal Chemical Research in Toxicology a method for measuring free radicals in cigarette smoke that could help improve our understanding of the relationship between these substances and health.
The researchers developed a standardized protocol for measuring free radicals in smoke first by using a control cigarette and a technique called electron paramagnetic resonance spectrometry. They then applied the same protocol to 27 varieties of commercial cigarettes.
The study found that the levels of gas-phase radicals ranged widely across the varieties while particulate-phase radicals showed less variability. An analysis of potential factors accounting for the differences found that highly ventilated cigarettes tended to produce lower levels of both gas- and particulate-phase free radicals.
The researchers say their method could be used to assess people's exposure to free radicals, which can help determine potential health effects.
http://pubs.acs.org/doi/abs/10.1021/acs.chemrestox.6b00359
Latest News
Zone 2 hepatocytes help in maintenance and regeneration of liver
Nanobody-mediated control of gene expression and epigenetic memory
Re-engineering Botox for Multiple Functions
New signaling pathway in neurons
Mother's diet boosts immune systems of premature infants
Other Top Stories
Increased Susceptibility of Females to Depression is Linked to Long Non-coding RNAs
Molecular effects of exercise
Stopping drug cravings with fewer side effects
Automated flow synthesis of proteins in the lab
Mechanism of action of anesthesia on consciousness solved!
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Nanobody-mediated control of gene expression and epigenetic memory
Interaction of 7SK with the Smn complex modulates snRNP production
Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum
Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemica…
Presentations
Liver Cirrhosis
Botulinum toxin
Bioplar Disorder
G-Protein-Coupled Receptors
Mood Disorders
Posters
ASCO-2020-CENTRAL NERVOUS SYSTEM TUMORS
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–IMMUNOTHERAPY
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–MOLECULARLY TARGETED AGENTS AND TUMOR BIOLOGY
ASCO-2020-CANCER PREVENTION, RISK REDUCTION, AND GENETICS
ASCO-2020-BREAST CANCER–METASTATIC